What happens to patients returning to dialysis after transplant failure? Data from the UK Renal Registry Dr Lynsey Webb 1, Dr Anna Casula 1, Dr Charlie.

Slides:



Advertisements
Similar presentations
Changes in graft function in long term renal transplant recipients – analysis by CKD stage and recipient characteristics U.P.Udayaraj, D.Ansell, R.Steenkamp,
Advertisements

Blood pressure and mortality risk in peritoneal dialysis patients in England and Wales Udaya P.Udayaraj, R.Steenkamp, F.Caskey, D.Ansell, C.Tomson UK Renal.
Blood pressure control in children following kidney transplantation in the UK Manish Sinha Evelina Childrens Hospital London UKRR and NHS Kidney Care Audit.
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
The future of haemodialysis in the UK RCP advanced medicine 2013 Cormac Breen Consultant Nephrologist Guy's and St Thomas' Hospitals London.
This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used for non-commercial study and educational.
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
An update from The UK Renal Registry Dr Fergus Caskey Medical Director, UK Renal Registry Annual Informatics Meeting, September 2014.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
CKD Conservative care and preparation for dialysis UK Renal Registry 2013 Annual Audit Meeting Dr Anirudh Rao Registrar, UK Renal Registry.
CKD: the primary/secondary care interface Daniel Ford Consultant Renal Physician UHCW.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
Exploring centre variation in RRT provision Dr Clare Castledine UKRR clinical fellow.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
INFLUENCE OF HLA MISMATCH ON GRAFT SURVIVAL IN RENAL TRASPLANTATION IN ADULTS IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
Survival comorbidity Mrs Retha Steenkamp Senior Statistician UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting.
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
Section G – Special Projects Scottish Renal Registry Report 2008 Published by the Information Services Division (ISD Scotland), Common Services Agency.
Renal Medicine David Johnson Princess Alexandra Hospital Brisbane, Australia A Comparison of APD vs CAPD on Patient Outcomes A Comparison of APD vs CAPD.
1 Influence of donor & recipient risk factors and the choice of immunosuppression Long term outcome after renal transplantation Influence of donor & recipient.
Why don’t indigenous dialysis patients receive transplants – waitlist or allocation? N. Khanal 1, P. Clayton 1, S. McDonald 1, M. Jose 2 1 The University.
Advanced CKD Study Daniel Ford UKRR Annual Audit Meeting June 2009.
Improving the utility of comorbidity records Retha Steenkamp UK Renal Registry.
Irbesartan Diabetic Nephropathy Trial (IDNT) Collaborative Study Group N Eng J Med 345: , 2001 Edmund J. Lewis, M.D. Muehrcke Family Professor of.
Dialysis: outcome and complications. Introduction Outcomes – 20%+ of dialysis patients die each year, 3YS diabetics ~50% Technical complications –PD –Haemo.
Why your data matters? How it helps patients, the NHS and research? How do I get UKRR data for research? Dr Retha Steenkamp Senior Statistician, UKRR.
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
CHAPTER 13 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato’ Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan.
UK Renal Registry 9 th Annual Report 2006 Fig 11.1 UK transplantation prevalence rate per million population by age and gender on 31/12/2005.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
Registry Report Highlights and Insights in 2007/8 User Group 2008.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
Survival after graft failure Dr Lynsey Webb Registrar UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting.
UKRR – HES linkage James Fotheringham Sheffield Kidney Institute.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
The Databases: Successes and Shortcomings in Renal Replacement Therapy Since 1989 European Renal Association and European Dialysis and Transplant Association.
CHAPTER 13 Renal Transplantation Goh Bak Leong Fan Kin Sing Rohan Malek Bin Dato’ Dr. Johan Rosnawati Yahya S. Prasad Menon Tan Si Yen Wong Hin Seng Source:
Access to renal transplantation Chris Dudley UKRR/UKT Joint analysis.
UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients
Chapter 3 Death and Survival on Dialysis Wong Hin Seng Ong Loke Meng Source: 20 th MDTR Report 2012, NRR.
Chronic Haemodialysis therapy in octogenarians with ESRF: demographics and outcomes from a single centre in England Dr Punit Yadav Dr Jyoti Baharani.
Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
소화기내과 김경엽 Gastroenterology 2011;140:
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
- Higher SBP visit-to-visit variability (SBV) has been associated
2016 Annual Data Report, Vol 2, ESRD, Ch 6
First-year death rates by modality figure 8
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 16th Annual Report
UK Renal Registry 18th Annual Report
UK Renal Registry 9th Annual Report 2006
Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic
UK Renal Registry 10th Annual Report 2007
CHAPTER 3 Death and Survival on Dialysis
North west Regional Day
Fig 6.1 Frequency of ischaemic heart disease in incident patients
UK Renal Registry 16th Annual Report
UK Renal Registry 14th Annual Report
UK Renal Registry 15th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 12th Annual Report
Dialysis outcomes in Australia & New Zealand
Stock and Flow of Haemodialysis Patients Australia
Presentation transcript:

What happens to patients returning to dialysis after transplant failure? Data from the UK Renal Registry Dr Lynsey Webb 1, Dr Anna Casula 1, Dr Charlie Tomson 2, Dr David Ansell 1, Prof Chris Maggs 1,3 and Prof Yoav Ben-Shlomo 4 1 UK Renal Registry, 2 Richard Bright Renal Unit, Bristol, 3 University of Hull and 4 University of Bristol.

Background (1) 22,300 prevalent UK kidney transplant patients Transplant failure rate 2.9% per year Previous studies mostly from North America Recent work has suggest increased mortality following graft failure Analyses limited by choice of control group

Background (2) ReferenceCountryNumber of cases Mortality riskControl group Fernandez- Fresnedo G. et al Trans Proc (2008) Spain74RR 2.05 (95% CI ) 194 incident cohort patients Gill J.S et al KI (2007) USA5, /100 pat yrs (95%CI ) 89,202 wait-listed patients 47,433 functioning transplants Kaplan B. et al AJT (2002) USAAnnual adjusted death rate 9.42% 78,564 transplant recipients Knoll G. et al AJT (2005) Canada607Adjusted HR 3.39 (95% CI ) 4,136 functioning transplants Rao P.S. et al NDT (2005) Canada675Adjusted HR 0.9 (95% CI ) 26,632 incident RRT patients Rao P.S. et al AJKD (2007) USA10,748HR1.78 (95%CI ) 175,436 patients wait-listed

Background (2) ReferenceCountryNumber of cases Mortality riskControl group Fernandez- Fresnedo G. et al Trans Proc (2008) Spain74RR 2.05 (95% CI ) 194 incident cohort patients Gill J.S et al KI (2007) USA5, /100 pat yrs (95%CI ) 89,202 wait-listed patients 47,433 functioning transplants Kaplan B. et al AJT (2002) USAAnnual adjusted death rate 9.42% 78,564 transplant recipients Knoll G. et al AJT (2005) Canada607Adjusted HR 3.39 (95% CI ) 4,136 functioning transplants Rao P.S. et al NDT (2005) Canada675Adjusted HR 0.9 (95% CI ) 26,632 incident RRT patients Rao P.S. et al AJKD (2007) USA10,748HR1.78 (95%CI ) 175,436 patients wait-listed

Methods (1) UKRR data Cases: Patients starting dialysis after 1 st transplant failure 01/01/ /09/2008 Controls: Patients starting RRT on dialysis 01/01/ /09/2008, and wait-listed for transplantation within 2 years Followed to death, or loss to follow up, or 31/12/2008 Censored if transplanted Exclusions: <18 yrs, missing primary renal diagnosis

Kaplan-Meier survival Hazard ratios calculated using Cox regression, adjusted for: Age (linear) Sex Diabetes Age x diabetes interaction Ethnicity (missing kept in as “missing”) Dialysis modality Methods (2)

Results (1): Cases 3,417 patients Mean age: 47.9 yrs Modality: Controls 11,280 patients Mean age: 47.4 yrs Modality: PD HD

Results (2): PRD

Results (3): KM survival (unadjusted) P<0.01 Log-rank test

Results (4): Risk of death in cases vs. controls Unadjusted HR HR 0-90 days 5.1 HR days 4.1 HR 1-2 years 3.2 HR 2-3 years 2.0 HR 3-5 years 1.1 HR 5+ years 0.9 P <0.01

Results (5): Risk of death in cases vs. controls Unadjusted HR + age HR 0-90 days HR days HR 1-2 years HR 2-3 years HR 3-5 years HR 5+ years P <0.01

Results (6): Risk of death in cases vs. controls Unadjusted HR + age+ sex HR 0-90 days HR days HR 1-2 years HR 2-3 years HR 3-5 years HR 5+ years P <0.01

Results (7): Risk of death in cases vs. controls Unadjusted HR + age+ sex+ DM + DM*age HR 0-90 days HR days HR 1-2 years HR 2-3 years HR 3-5 years HR 5+ years P <0.01

Results (8): Risk of death in cases vs. controls Unadjusted HR + age+ sex+ DM + DM*age + ethnicity HR 0-90 days HR days HR 1-2 years HR 2-3 years HR 3-5 years HR 5+ years P <0.01

Results (9): Risk of death in cases vs. controls Unadjusted HR + age+ sex+ DM + DM*age + ethnicity + HD or PD HR 0-90 days HR days HR 1-2 years HR 2-3 years HR 3-5 years HR 5+ years P <0.01

0-90 days days1-2 years2-3 years3-5 years Unadjusted HR Adjusted HR Adjusted HR Results (10): Sub group 504 Pre-emptive transplants Controls – incident wait-listed dialysis patients All failed transplants P <0.01

Limitations Identifying best control group Controls not exposed to long term immunosuppression Cases longer cumulative time on RRT Impact of comorbidity Data capture issues UKRR coverage only 100% since 2008 Patients with graft failure, dialysed for a short time before death ? Not captured Missing data

Conclusions Significant increase in mortality risk in the 1st year following transplant failure –4.1 x more likely to die between days if returning to dialysis after graft failure rather than starting dialysis as initial RRT –4.2 x more likely to die between days if starting dialysis after failure of pre-emptive transplant Increased risk of death continues to 5 years post-graft failure

Future work (1) Sudden vs. predictable graft loss Duration of immunosuppression Transplant nephrectomy Dialysis modality Attainment of RA/KDOQI targets Nutritional status Listing for retransplantation Frequency of outpatient clinics Structure/staffing of clinic Vascular access at dialysis start Contact with renal services/admissions Potentially modifiable variables

Future work (2) HES linkage: analysis of morbidity and transplant nephrectomy rates Case control study examining patient and centre level factors associated with survival after graft failure European registry collaboration (planned 2011):  increase statistical power  geographical variation  allow analysis of cause-specific death

Acknowledgements  Many thanks to:  UKRR transplant sub-group  UK renal centres and patients  Scottish Renal Registry  Data and systems staff (UKRR)  Biostatisticians (UKRR)  NHS Blood and Transplant

Transplant CKD management Parameter Stage 5T (eGFR <15) Dialysis Patients Hb mean11.0 ± Hb % < 10 g/dl32 **14 Hb % < 11 g/dl51 **30 Ferritin median ng/ml202 **393 Ferritin %< 100 ng/ml28 **6 % Systolic BP > 130 mmHg74 **53 % Diastolic BP > 80 mmHg68 **62 % Chol > 200 mg/dl34 **17 **Chi-square P <0.001